Panelists underscore the importance of patient education in improving treatment adherence.
This is a video synopsis/summary of a Stakeholder Summit involving:
Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD.
Kabiri discusses the significant impact of dry eye disease (DED) on quality of life, including higher rates of depression compared to other ocular conditions. Red, irritated eyes also affect self-image and enjoyment of activities. Patient perspectives on DED help identify educational gaps for improved adherence.
Haumschild then asks about strategies to improve DED adherence. Parekh notes the value of direct-to-consumer DED awareness campaigns in informing patients and driving inquiries regarding specialty care. Education around DED encompasses digital patient communities, eye care team counseling, pharmacy staff, professional societies, and industry. With DED’s rising prominence, education helps prevent misinformation, empowers patients to seek appropriate treatment, and facilitates proper self-management for better outcomes.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More